Walgreens Boots Alliance (WBA) Proxy Filing summary

Executive summary

• A special meeting is called for shareholders to vote on a merger agreement under which the company will be acquired by affiliates of Sycamore Partners, with shareholders receiving $11.45 in cash and a contingent right to up to $3.00 per share from future asset sales (DAP Rights).

• The board, excluding recused directors, unanimously recommends approval of the merger, citing a significant premium to unaffected share price, limited alternative offers, and fairness opinions from Centerview and Morgan Stanley.

• The transaction is structured as a two-step closing, with the company becoming a wholly owned subsidiary of the acquirer and delisting from Nasdaq.

Voting matters and shareholder proposals

• Shareholders will vote on: (1) the merger agreement, (2) adjournment of the meeting if needed, and (3) a nonbinding advisory vote on executive compensation related to the merger.

• Approval of the merger requires both a majority of all outstanding shares and a majority of unaffiliated shares voted.

• SP Investors, holding about 17% of shares, have entered into a voting agreement to support the merger.

Board of directors and corporate governance

• Two directors, Stefano Pessina and John Lederer, recused themselves from deliberations due to conflicts of interest.

• The board established a transaction committee to oversee negotiations and process integrity.

• After the merger, the board will be replaced by designees of the acquirer.